Skip to main content
OpenTrials
Recruiting

NCT Number: NCT06789666

Digital Art Therapy for Young Cancer Survivors

This is a single-site, single-arm, interventional study assessing the feasibility of the ARTCan Therapy Application (App) and whether it is an acceptable means of administering art therapy to young adult cancer survivors. The ARTCan Therapy App guides participants through a 6-week digital art therapy program. Subjects will participate in weekly art therapy prompts guided by the app and will complete weekly mental health quality of life (MHQoL) surveys during the intervention. In addition, baseline and end-of-intervention patient-reported outcome measures (PROMIS-DSF8a) and an acceptability survey will be administered. The hypothesis is that digital art therapy is feasible for young adult cancer survivors with self-reported mood issues and is an acceptable means of administering art therapy in the patient population.

Recruiting

Interested in participating?

Request Info

Key information

Age range

18 year–25 year

Sex eligibility

All sexes

Study type

Interventional

Phase

Not applicable

Primary location

Lineberger Comprehensive Cancer Center

Chapel Hill, North Carolina, 27599, United States

Location status: Recruiting

Location contact

Bridget Pemberton-Smith, LLC

SUB_INVESTIGATOR

Claudia Rebola

SUB_INVESTIGATOR

Devine McCarthy

CONTACT

[email protected]

919-445-4208

Heekyoung Jung

SUB_INVESTIGATOR

Patricia Brock

CONTACT

[email protected]

+1 919-962-8491

Soma Sengupta, MD

PRINCIPAL_INVESTIGATOR

Zev Nakamura, MD

SUB_INVESTIGATOR

About this study

The ARTCan application has been designed to define therapy strategies for the care of patients; it emerges from a unique collaboration in the disciplines of design, art, art therapy, and medicine from the College of Design, Architecture, Art, and Planning (DAAP) at the University of Cincinnati (UC) and the School of Medicine, the University of North Carolina, Chapel Hill. The relevance of the application design was to enable the trans-disciplinary team to experiment with proof of the following concepts: 1) technology-based tools and feasibility studies for new lines of research in treatment; 2) research that embraces intellectual diversity by merging the creative disciplines; and 3) addressing issues of health and well-being of patients. This study is testing whether the digital art therapy application "Art Therapy Can Do" (ARTCan) is a feasible means of administering art therapy to young cancer survivors. The study is funded by the Ian's Friends Foundation and the Weatherspoon Foundation.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

In order to participate in this study a subject must meet all of the eligibility criteria outlined below.

  • Written informed assent and parental consent obtained to participate in the study and HIPAA authorization for release of personal health information.
  • Subject is willing and able to comply with study procedures based on the judgment of the investigator.
  • Age 18-25 years at the time of consent.
  • Childhood cancer survivor, defined as having cancer between birth 17 years of age and who has completed cancer treatment.
  • Reliable internet connection and access to a computer, smartphone, or iPad to support application and virtual study visits.
  • Answers "yes" to the question "Do you experience mood issues (yes or no)?".

Exclusion criteria

  • All subjects meeting any of the exclusion criteria at baseline will be excluded from study participation.
  • Patients who lack interest in art. Screening question: Are you open to making art on a scale from 1-5 (1 being not at all, and 5 being very much; must score 3 or higher).
  • Subjects who lack basic technology skills (Screening question: On a scale of 1-5 (1 being uncomfortable, and 5 being very comfortable), how would you rate your comfort using websites. Must score 3 or higher).
  • Subjects unable to provide consent.
  • Other conditions or factors which in the opinion of the Pl would not make the patient a good candidate for the study.

Treatment and study plan

ARTCan App

Behavioral

The ARTCan App is an art therapy technology application program. The application can be accessed via the web (via computer, phone, or on a device such as an iPad). With the use of the application, participants complete weekly sessions that culminate in an "art" piece. Note that participants are not required to have expertise in drawing; developing art skills or assessing the quality of art pieces is not the focus of the ARTCan program.

Subjects will upload a photo of the art they created to this application to show proof of completion of art therapy. They will also answer questions specific to the art therapy theme for the week.

Primary outcomes

  1. Feasibility of art therapy

    Time frame: Up to 6 weeks

    The feasibility of art therapy will be determined by the proportion of participants who complete art therapy. The proportion of participants who complete 4 of the 6 art therapy modules will be determined. A completion rate of 10 out of 15 participants will be deemed feasible.

Secondary outcomes

  1. Acceptability of art therapy

    Time frame: at 6 week

    Acceptability of art therapy will be measured as the proportion of participants responded to the survey questionnaire administered at the end of the intervention. The survey questionnaire will be taken via a web-based application as post- Intervention Assessment. Question: 1) Please provide your impression of the ARTCan App: A) I like the App B) I don't like the.

Study contacts

Contact information is provided by the study sponsor or research team.

Devin McCarthy

CONTACT

[email protected]

919-445-4208

Patricia Brock

CONTACT

[email protected]

919-962-8491

Sponsors and collaborators

Lead sponsor

UNC Lineberger Comprehensive Cancer Center

Other

Collaborators

  • Ian's Friends Foundation

Registry information

Official study title

Feasibility of a Digital Art Therapy Application Designed to Improve Quality of Life in Young Cancer Survivors

Important dates

Study start
2025
Primary completion
2027
Study completion
2027
First posted
Jan 23, 2025
Registry last updated
Sep 16, 2025

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.